Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2007
10/18/2007WO2007116078A1 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides
10/18/2007WO2007116061A1 1-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro [4.5]dec-3-en-2-one derivatives and their use as glycine transporter inhibitors
10/18/2007WO2007115938A1 5-amido-2-carboxamide indoles
10/18/2007WO2007115935A1 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
10/18/2007WO2007115798A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
10/18/2007WO2007115670A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
10/18/2007WO2007115410A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007115403A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007100880A8 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
10/18/2007WO2007096763A3 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
10/18/2007WO2007092531A3 Compounds and compositions as protein kinase inhibitors
10/18/2007WO2007084415A3 Compounds for the treatment of inflammatory disorders
10/18/2007WO2007076473A3 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases
10/18/2007WO2007075629A3 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
10/18/2007WO2006087543A8 Antibacterial piperidine derivatives
10/18/2007US20070244158 Piperdine Compound and Process for Preparing the Same
10/18/2007US20070244156 Sulfonylamino-acetic acid derivatives
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244138 antiinflammatory agents
10/18/2007US20070244137 Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes
10/18/2007US20070244136 Quinazoline Derivatives
10/18/2007US20070244130 Compounds and Compositions as Ppar Modulators
10/18/2007US20070244120 Inhibition of raf kinase using substituted heterocyclic ureas
10/18/2007US20070244118 Cyclic Amide Derivative, and Its Production and Use
10/18/2007US20070244117 Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof
10/18/2007US20070244114 Compounds and therapeutical use thereof
10/18/2007US20070244113 Compounds and therapeutical use thereof
10/18/2007US20070244112 Novel tetrahydropyridothiophenes
10/18/2007US20070244109 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases
10/18/2007US20070244103 Novel Compounds Having an Anti-Bacterial Activity
10/18/2007US20070244099 Such as 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylic acid-{(R)-1-(3,4-diethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amide; calcitonin gene related peptide (CGRP); for treatment of migraines; radioimmunoassay
10/18/2007US20070244098 Dual Small Molecule Inhibitors of Cancer and Angiogenesis
10/18/2007US20070244086 3-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
10/18/2007US20070243266 N-[1(R)-(3H-imidazo[4,5-b]pyridin-2-yl)ethyl]-2-fluoro-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -carboxamide; osteoporosis, periodontal disease, bone fracture, frailty, sarcopenia, depression, sexual dysfunction, and cognitive decline; tissue-selective androgen receptor modulators(SARM)
10/18/2007US20070243134 Receptor Selective Cannabimimetic Aminoalkylindoles
10/18/2007DE69233686T2 Heteoaryl-Piperidine und Piperazine und ihre Anwendung als antipsychotisches und analgetisches Mittel Heteoaryl-piperidines and piperazines and their use as antipsychotic and analgesic agent
10/18/2007DE102006017827A1 Neue kristalline Verbindungen New crystalline compounds
10/18/2007CA2652109A1 Compositions and methods for modulating gated ion channels
10/18/2007CA2649209A1 Enzyme inhibitors
10/18/2007CA2649000A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
10/18/2007CA2648914A1 Pyridyloxadiazole substituted compounds and compositions
10/18/2007CA2648804A1 Benzamide derivatives as inhibitors of histone deacetylase
10/18/2007CA2648687A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
10/18/2007CA2648529A1 Quinazolines for pdk1 inhibition
10/18/2007CA2648496A1 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides
10/18/2007CA2648335A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
10/18/2007CA2648323A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007CA2648074A1 11.beta.-hydroxysteroid dehydrogenase type 1 active compounds
10/18/2007CA2648055A1 Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/18/2007CA2647945A1 2-(pyridin-2-yl)-pyrimidines for use as fungicides
10/18/2007CA2647448A1 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
10/18/2007CA2647440A1 5-amido-2-carboxamide indoles
10/18/2007CA2646069A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/18/2007CA2644391A1 Organic compounds
10/18/2007CA2643011A1 Quinolones useful as inducible nitric oxide synthase inhibitors
10/17/2007EP1845087A1 Hydroxyphenyl derivatives and biological applications thereof
10/17/2007EP1844780A2 Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
10/17/2007EP1844778A1 Agent for prevention/therapy of disease caused by keratinocyte growth
10/17/2007EP1844042A1 Indole derivatives for treating viral infections
10/17/2007EP1844037A1 Chemical compounds
10/17/2007EP1844036A1 Salts of aripiprazole
10/17/2007EP1844035A1 Amino-pyridines as inhibitors of beta-secretase
10/17/2007EP1844013A1 Indoles useful in the treatment of inflammation
10/17/2007EP1844003A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor
10/17/2007EP1843820A1 Multicyclic bis-amide mmp inhibitors
10/17/2007EP1843767A1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders.
10/17/2007EP1742909A4 Anionic-sweetener-based ionic liquids and methods of use thereof
10/17/2007EP1648871B1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1341769B1 Bacterial gyrase inhibitors and uses thereof
10/17/2007EP1267848B1 Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer
10/17/2007EP1218353B1 Quinazoline derivatives
10/17/2007EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007EP1173432B1 Piperidine-indole compounds having 5-ht6 affinity
10/17/2007CN101056881A Metal complex compound and organic electroluminescent device using same
10/17/2007CN101056871A Novel anthranilamide pyridinureas as vegf receptor kinase inhibitors
10/17/2007CN101056870A Nicotinamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors
10/17/2007CN101056869A Method and apparatus for producing oxidized compound
10/17/2007CN101056866A 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
10/17/2007CN101056864A Method for preparing pyrimidine compound
10/17/2007CN100343668C Novel fluorescent label compounds
10/17/2007CN100343338C Yellow anionic disazo dyes
10/17/2007CN100343239C IL-5 inhibiting azauracil pyrimidine derivatives
10/17/2007CN100343238C Quinazoline derivatives as antitumor agents
10/17/2007CN100343237C Amide derivative and medicine
10/16/2007US7282608 Inhibitors of histone deacetylase
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282589 Acid addition salt of optically active piperidine compound and process for preparing the same
10/16/2007US7282587 Process for the preparation of 10,11-dihydro-5h-dibenzo[a,d]cyclohept-5-enes and derivatives thereof
10/16/2007US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/16/2007US7282516 CB1, cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
10/16/2007US7282511 Isatine derivatives with neurotrophic activity
10/16/2007US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases
10/16/2007US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
10/16/2007US7282507 Indole derivatives as selective androgen receptor modulators (SARMS)
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007US7282500 Nitrogen compounds such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic Acid (2-morpholin-4-yl-ethyl)-amide, used as anticarcinogenic agents and for prophylaxis of brain disorders
10/16/2007US7282498 Substituted fused pyrroleoximes and fused pyrazoleoximes
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
1 ... 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 ... 1080